Evolus (EOLS) EBT Margin (2019 - 2026)

Evolus (EOLS) posted EBT Margin of 14.24% for Q1 2026, down 2597.63% on a QoQ basis from 0.57% in Q4 2025, and up 1322.0% year-over-year from 1.0% in Q1 2025.

Evolus (EOLS) EBT Margin (2019 - 2026) Analysis & Trends

Evolus' EBT Margin history runs 8 years deep, the most recent figure standing at 14.24% for Q1 2026.

  • Quarterly EBT Margin rose 1322.0% year-over-year to 14.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.1% (up 605.0% YoY) and the FY2025 annual result came in at 17.15%, up 154.0% from the prior year.
  • EBT Margin was 14.24% for Q1 2026 at Evolus, down from 0.57% in the prior quarter.
  • Across five years, EBT Margin topped out at 0.57% in Q4 2025 and bottomed at 63.08% in Q2 2022.
  • A 5-year average of 29.18% and a median of 27.47% in 2025 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin slumped 10401 bps — and 2023, when it soared 2637 bps.
  • Evolus' EBT Margin stood at 30.03% in 2022, then jumped by 36 bps to 19.22% in 2023, then soared by 58 bps to 8.04% in 2024, then jumped by 107 bps to 0.57% in 2025, then slumped by 2598 bps to 14.24% in 2026.
  • Business Quant data shows EOLS's EBT Margin at 14.24% in Q1 2026, 0.57% in Q4 2025, and 22.58% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -14.24%

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.24%
Dec 31, 2025 0.57%
Sep 30, 2025 -22.58%
Jun 30, 2025 -24.63%
Mar 31, 2025 -27.47%
Dec 31, 2024 -8.04%
Sep 30, 2024 -31.16%
Jun 30, 2024 -16.90%
Mar 31, 2024 -22.01%
Dec 31, 2023 -19.22%
Sep 30, 2023 -33.79%
Jun 30, 2023 -36.71%
Mar 31, 2023 -35.40%
Dec 31, 2022 -30.03%
Sep 30, 2022 -59.78%
Jun 30, 2022 -63.08%
Mar 31, 2022 -51.62%
Dec 31, 2021 -52.42%
Sep 30, 2021 -72.80%
Jun 30, 2021 -59.74%